Cargando…
ATR mediates cisplatin resistance in a p53 genotype-specific manner
The protein kinase encoded by the ataxia-telangiectasia and Rad3-related (ATR) gene is activated by DNA damaging agents that are frequently employed as anticancer therapeutics. Inhibition of ATR expression in cultured cancer cells has been demonstrated to increase sensitivity to chemotherapeutic dru...
Autores principales: | Sangster-Guity, N, Conrad, BH, Papadopoulos, N, Bunz, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107343/ https://www.ncbi.nlm.nih.gov/pubmed/21258400 http://dx.doi.org/10.1038/onc.2010.624 |
Ejemplares similares
-
NSC109268 potentiates cisplatin-induced cell death in a p53-independent manner
por: Shankar, Eswar, et al.
Publicado: (2010) -
The Impact of p53 Dysfunction in ATR Inhibitor Cytotoxicity and Chemo- and Radiosensitisation
por: Middleton, Fiona K., et al.
Publicado: (2018) -
UV-Induced Nuclear Import of XPA Is Mediated by Importin-α4 in An ATR-Dependent Manner
por: Li, Zhengke, et al.
Publicado: (2013) -
ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation
por: Gomes, Luciana Rodrigues, et al.
Publicado: (2019) -
XPA-Mediated Regulation of Global Nucleotide Excision Repair by ATR Is p53-Dependent and Occurs Primarily in S-Phase
por: Li, Zhengke, et al.
Publicado: (2011)